Geode Capital Management
CSBR icon

Geode Capital Management’s Champions Oncology CSBR Stock Holding History

Geode Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Sell
76,300
-877
-1% -$5.29K ﹤0.01% 3627
2026
Q1 		$444K Buy
77,177
+1,358
+2% +$8.63K ﹤0.01% 3630
2025
Q4 		$524K Buy
75,819
+1,410
+2% +$9.39K ﹤0.01% 3568
2025
Q3 		$482K Sell
74,409
-776
-1% -$5.47K ﹤0.01% 3629
2025
Q2 		$554K Buy
75,185
+51
+0.1% +$360 ﹤0.01% 3524
2025
Q1 		$652K Buy
75,134
+8,623
+13% +$87.4K ﹤0.01% 3444
2024
Q4 		$570K Buy
66,511
+1,447
+2% +$7.28K ﹤0.01% 3560
2024
Q3 		$317K Buy
65,064
+1,978
+3% +$9.28K ﹤0.01% 3746
2024
Q2 		$326K Buy
63,086
+972
+2% +$4.74K ﹤0.01% 3733
2024
Q1 		$304K Buy
62,114
+765
+1% +$4.48K ﹤0.01% 3793
2023
Q4 		$332K Hold
61,349
– – ﹤0.01% 3757
2023
Q3 		$382K Buy
61,349
+2,433
+4% +$15.4K ﹤0.01% 3705
2023
Q2 		$371K Buy
58,916
+8,464
+17% +$43.7K ﹤0.01% 3756
2023
Q1 		$203K Buy
50,452
+2
+0% +$9 ﹤0.01% 4044
2022
Q4 		$227K Buy
50,450
+2,812
+6% +$18.4K ﹤0.01% 4028
2022
Q3 		$357K Hold
47,638
– – ﹤0.01% 3905
2022
Q2 		$385K Hold
47,638
– – ﹤0.01% 3903
2022
Q1 		$387K Hold
47,638
– – ﹤0.01% 4072
2021
Q4 		$381K Hold
47,638
– – ﹤0.01% 4179
2021
Q3 		$486K Buy
47,638
+4,685
+11% +$47.7K ﹤0.01% 4038
2021
Q2 		$441K Sell
42,953
-49,865
-54% -$506K ﹤0.01% 4000
2021
Q1 		$1.05M Buy
92,818
+641
+0.7% +$7.44K ﹤0.01% 3539
2020
Q4 		$994K Buy
92,177
+393
+0.4% +$4.05K ﹤0.01% 3376
2020
Q3 		$849K Sell
91,784
-220
-0.2% -$1.96K ﹤0.01% 3267
2020
Q2 		$879K Buy
92,004
+48,269
+110% +$411K ﹤0.01% 3181
2020
Q1 		$323K Buy
43,735
+204
+0.5% +$1.43K ﹤0.01% 3406
2019
Q4 		$362K Buy
43,531
+396
+0.9% +$2.44K ﹤0.01% 3609
2019
Q3 		$243K Hold
43,135
– – ﹤0.01% 3704
2019
Q2 		$337K Hold
43,135
– – ﹤0.01% 3603
2019
Q1 		$422K Buy
43,135
+2,816
+7% +$28.1K ﹤0.01% 3498
2018
Q4 		$314K Buy
40,319
+16,025
+66% +$184K ﹤0.01% 3541
2018
Q3 		$424K Buy
+24,294
New +$216K ﹤0.01% 3525

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management's CSBR Position: Q2 2026 in Review

Geode Capital Management reduced its Champions Oncology (CSBR) stake by 1.1% in Q2 2026, selling an estimated $5.29K and leaving 76,300 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

Geode Capital Management first reported a position in CSBR in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.05M in Q1 2021. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Geode Capital Management held 76,300 shares of Champions Oncology worth $470K as of Q2 2026.
  • Geode Capital Management sold 877 Champions Oncology shares in Q2 2026, an estimated $5.29K.
  • Champions Oncology made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3627 holding.
  • Geode Capital Management first reported a position in Champions Oncology in Q3 2018 and has held it in 32 quarters since.
  • Geode Capital Management's Champions Oncology position peaked at $1.05M in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.